{"anticipatedPostingDate":"2027-01","denomUnitsSelected":"Participants","description":"DOR was defined as the time from the first documentation of objective tumor response (CR or PR) to the first documentation of tumor progression (per Cheson 2007) or death, whichever came first. Participants without progression or death were censored. DOR was only calculated for the subset of participants achieving a CR or PR. CR and PR per Cheson 2007: CR was defined as complete disappearance of all detectable clinical evidence of disease and disease-related symptoms if present before therapy and PR was defined as at least a 50% decrease in sum of the product of the diameters (SPD) of up to six of the largest dominant nodes or nodal masses. Kaplan-Meier method was used for analysis.","reportingStatus":"NOT_POSTED","timeFrame":"From the first documented CR or PR until the first documentation of tumor progression, death or censoring date, whichever came first (up to 61.7 months)","title":"Duration of Response (DOR) Per BICR (Cheson 2007) by Central CD30 Assessment","type":"SECONDARY"}